_id
690db025ccc777a4e85d0b5b
Ticker
APYX
Name
Apyx Medical Inc
Exchange
NASDAQ
Address
5115 Ulmerton Road, Clearwater, FL, United States, 33760-4004
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://apyxmedical.com
Description
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Last Close
3.99
Volume
200459
Current Price
3.86
Change
-3.2581453634085293
Last Updated
2025-11-28T12:19:51.800Z
Image
data:image/webp;base64,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
Ipo Date
1987-01-01T00:00:00.000Z
Market Cap
164467168
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9533333333333333
Sentiment Sources
3
Rating
3.6667
Target Price
6
Strong Buy
1
Buy
0
Hold
2
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
12877000
Cost Of Revenue
4580000
Gross Profit
8297000
Operating Expenses
9129000
Operating Income
-832000
Interest Expense
1413000
Pretax Income
-1877000
Net Income
-1984000
Eps
-0.0487122197942498
Dividends Per Share
-
Shares Outstanding
41014254
Income Tax Expense
78000
EBITDA
-332000
Operating Margin
-6.461132251300769
Total Other Income Expense Net
-1045000
Cash
25135000
Short Term Investments
-
Receivables
12995000
Inventories
9145000
Total Current Assets
48788000
Property Plant Equipment
6765000
Total Assets
57365000
Payables
3220000
Short Term Debt
414000
Long Term Debt
34607000
Total Liabilities
51285000
Equity
5848000
Depreciation
164000
Change In Working Capital
-2719000
Cash From Operations
-3536000
Capital Expenditures
518999
Cash From Investing
-519000
Cash From Financing
45000
Net Change In Cash
-4166000
PE
-
PB
27.7887670998632
ROE
-33.926128590971274
ROA
-3.458554867950841
FCF
-4054999
Fcf Percent
-0.314902461753514
Piotroski FScore
0
Health Score
8
Deep Value Investing Score
2.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
3
Net Net Investing Score
1
Quality Investing Score
1.5
Value Investing Score
2
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
12877000
Quarters > 0 > income Statement > cost Of Revenue
4580000
Quarters > 0 > income Statement > gross Profit
8297000
Quarters > 0 > income Statement > operating Expenses
9129000
Quarters > 0 > income Statement > operating Income
-832000
Quarters > 0 > income Statement > interest Expense
1413000
Quarters > 0 > income Statement > pretax Income
-1877000
Quarters > 0 > income Statement > net Income
-1984000
Quarters > 0 > income Statement > eps
-0.0487122197942498
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
40729000
Quarters > 0 > income Statement > income Tax Expense
78000
Quarters > 0 > income Statement > EBITDA
-332000
Quarters > 0 > income Statement > operating Margin
-6.461132251300769
Quarters > 0 > income Statement > total Other Income Expense Net
-1045000
Quarters > 0 > balance Sheet > cash
25135000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
12995000
Quarters > 0 > balance Sheet > inventories
9145000
Quarters > 0 > balance Sheet > total Current Assets
48788000
Quarters > 0 > balance Sheet > property Plant Equipment
6765000
Quarters > 0 > balance Sheet > total Assets
57365000
Quarters > 0 > balance Sheet > payables
3220000
Quarters > 0 > balance Sheet > short Term Debt
414000
Quarters > 0 > balance Sheet > long Term Debt
34607000
Quarters > 0 > balance Sheet > total Liabilities
51285000
Quarters > 0 > balance Sheet > equity
5848000
Quarters > 0 > cash Flow > net Income
-1984000
Quarters > 0 > cash Flow > depreciation
164000
Quarters > 0 > cash Flow > change In Working Capital
-2719000
Quarters > 0 > cash Flow > cash From Operations
-3536000
Quarters > 0 > cash Flow > capital Expenditures
518999
Quarters > 0 > cash Flow > cash From Investing
-519000
Quarters > 0 > cash Flow > cash From Financing
45000
Quarters > 0 > cash Flow > net Change In Cash
-4166000
Quarters > 0 > ratios > PE
-0.0487122197942498
Quarters > 0 > ratios > PB
27.7887670998632
Quarters > 0 > ratios > ROE
-33.926128590971274
Quarters > 0 > ratios > ROA
-3.458554867950841
Quarters > 0 > ratios > FCF
-4054999
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-0.314902461753514
Quarters > 0 > health Score
8
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
11373000
Quarters > 1 > income Statement > cost Of Revenue
4290000
Quarters > 1 > income Statement > gross Profit
7083000
Quarters > 1 > income Statement > operating Expenses
9657000
Quarters > 1 > income Statement > operating Income
-2574000
Quarters > 1 > income Statement > interest Expense
1393000
Quarters > 1 > income Statement > pretax Income
-3689000
Quarters > 1 > income Statement > net Income
-3778000
Quarters > 1 > income Statement > eps
-0.09275945886223576
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
40729000
Quarters > 1 > income Statement > income Tax Expense
49000
Quarters > 1 > income Statement > EBITDA
-2164000
Quarters > 1 > income Statement > operating Margin
-22.632550778158798
Quarters > 1 > income Statement > total Other Income Expense Net
-1115000
Quarters > 1 > balance Sheet > cash
29301000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
11248000
Quarters > 1 > balance Sheet > inventories
8192000
Quarters > 1 > balance Sheet > total Current Assets
49915000
Quarters > 1 > balance Sheet > property Plant Equipment
6550000
Quarters > 1 > balance Sheet > total Assets
58188000
Quarters > 1 > balance Sheet > payables
2893000
Quarters > 1 > balance Sheet > short Term Debt
398000
Quarters > 1 > balance Sheet > long Term Debt
34365000
Quarters > 1 > balance Sheet > total Liabilities
50732000
Quarters > 1 > balance Sheet > equity
7253000
Quarters > 1 > cash Flow > net Income
-3738000
Quarters > 1 > cash Flow > depreciation
132000
Quarters > 1 > cash Flow > change In Working Capital
1293000
Quarters > 1 > cash Flow > cash From Operations
-1233000
Quarters > 1 > cash Flow > capital Expenditures
265000
Quarters > 1 > cash Flow > cash From Investing
-265000
Quarters > 1 > cash Flow > cash From Financing
25000
Quarters > 1 > cash Flow > net Change In Cash
-1710000
Quarters > 1 > ratios > PE
-0.09275945886223576
Quarters > 1 > ratios > PB
22.40572314904178
Quarters > 1 > ratios > ROE
-52.08879084516752
Quarters > 1 > ratios > ROA
-6.492747645562659
Quarters > 1 > ratios > FCF
-1498000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.13171546645564056
Quarters > 1 > health Score
9
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
9430000
Quarters > 2 > income Statement > cost Of Revenue
3765000
Quarters > 2 > income Statement > gross Profit
5665000
Quarters > 2 > income Statement > operating Expenses
8716000
Quarters > 2 > income Statement > operating Income
-3051000
Quarters > 2 > income Statement > interest Expense
1376000
Quarters > 2 > income Statement > pretax Income
-4123000
Quarters > 2 > income Statement > net Income
-4150000
Quarters > 2 > income Statement > eps
-0.11676326599516065
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
35542000
Quarters > 2 > income Statement > income Tax Expense
49000
Quarters > 2 > income Statement > EBITDA
-2609000
Quarters > 2 > income Statement > operating Margin
-32.3541887592789
Quarters > 2 > income Statement > total Other Income Expense Net
-1072000
Quarters > 2 > balance Sheet > cash
31011000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
11645000
Quarters > 2 > balance Sheet > inventories
7685000
Quarters > 2 > balance Sheet > total Current Assets
51851000
Quarters > 2 > balance Sheet > property Plant Equipment
6537000
Quarters > 2 > balance Sheet > total Assets
60160000
Quarters > 2 > balance Sheet > payables
2305000
Quarters > 2 > balance Sheet > short Term Debt
374000
Quarters > 2 > balance Sheet > long Term Debt
34127000
Quarters > 2 > balance Sheet > total Liabilities
49516000
Quarters > 2 > balance Sheet > equity
10511000
Quarters > 2 > cash Flow > net Income
-4150000
Quarters > 2 > cash Flow > depreciation
138000
Quarters > 2 > cash Flow > change In Working Capital
2593000
Quarters > 2 > cash Flow > cash From Operations
-702000
Quarters > 2 > cash Flow > capital Expenditures
55000
Quarters > 2 > cash Flow > cash From Investing
-55000
Quarters > 2 > cash Flow > cash From Financing
25000
Quarters > 2 > cash Flow > net Change In Cash
-730000
Quarters > 2 > ratios > PE
-0.11676326599516065
Quarters > 2 > ratios > PB
13.491825706402818
Quarters > 2 > ratios > ROE
-39.48244696032728
Quarters > 2 > ratios > ROA
-6.898271276595745
Quarters > 2 > ratios > FCF
-757000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.08027571580063626
Quarters > 2 > health Score
9
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
14222000
Quarters > 3 > income Statement > cost Of Revenue
5258000
Quarters > 3 > income Statement > gross Profit
8964000
Quarters > 3 > income Statement > operating Expenses
12012000
Quarters > 3 > income Statement > operating Income
-3048000
Quarters > 3 > income Statement > interest Expense
1653000
Quarters > 3 > income Statement > pretax Income
-4570000
Quarters > 3 > income Statement > net Income
-4628000
Quarters > 3 > income Statement > eps
-0.12110427842470234
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
38215000
Quarters > 3 > income Statement > income Tax Expense
89000
Quarters > 3 > income Statement > EBITDA
-2775000
Quarters > 3 > income Statement > operating Margin
-21.43158486851357
Quarters > 3 > income Statement > total Other Income Expense Net
-1522000
Quarters > 3 > balance Sheet > cash
31741000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
15480000
Quarters > 3 > balance Sheet > inventories
7564000
Quarters > 3 > balance Sheet > total Current Assets
56440000
Quarters > 3 > balance Sheet > property Plant Equipment
6738000
Quarters > 3 > balance Sheet > total Assets
64842000
Quarters > 3 > balance Sheet > payables
2615000
Quarters > 3 > balance Sheet > short Term Debt
355000
Quarters > 3 > balance Sheet > long Term Debt
33893000
Quarters > 3 > balance Sheet > total Liabilities
50507000
Quarters > 3 > balance Sheet > equity
14210000
Quarters > 3 > cash Flow > net Income
-4659000
Quarters > 3 > cash Flow > depreciation
142000
Quarters > 3 > cash Flow > change In Working Capital
-394000
Quarters > 3 > cash Flow > cash From Operations
-2937000
Quarters > 3 > cash Flow > capital Expenditures
245000
Quarters > 3 > cash Flow > cash From Investing
-245000
Quarters > 3 > cash Flow > cash From Financing
6760000
Quarters > 3 > cash Flow > net Change In Cash
3728000
Quarters > 3 > ratios > PE
-0.12110427842470234
Quarters > 3 > ratios > PB
10.730320197044335
Quarters > 3 > ratios > ROE
-32.56861365235749
Quarters > 3 > ratios > ROA
-7.137349248943586
Quarters > 3 > ratios > FCF
-3182000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.2237378709042329
Quarters > 3 > health Score
9
Valuation > metrics > PE
-0.0487122197942498
Valuation > metrics > PB
27.7887670998632
Valuation > final Score
20
Valuation > verdict
826.3% Overvalued
Profitability > metrics > ROE
-33.926128590971274
Profitability > metrics > ROA
-4.066573747642863
Profitability > metrics > Net Margin
-0.1540731536848645
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
8.769664842681259
Risk > metrics > Interest Coverage
-0.5888181174805379
Risk > final Score
4
Risk > verdict
High
Liquidity > metrics > Current Ratio
13.425426527242708
Liquidity > metrics > Quick Ratio
10.908915795266923
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-1
Prev Risks > 1
-3
Prev Risks > 2
-1
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T13:44:20.334Z
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AHow AYON Momentum Is Rewriting the Growth Story for Apyx Medical Yahoo Finance
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$6
Analyst Picks
Strong Buy
1
Buy
0
Hold
2
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 41.13% of the total shares of Apyx Medical Inc
1.
Nantahala Capital Management, LLC(8.8263%)
since
2025/06/30
2.
Archon Capital Management LLC(8.6767%)
since
2025/06/30
3.
Royce & Associates, LP(6.4509%)
since
2025/06/30
4.
Vanguard Group Inc(3.9021%)
since
2025/06/30
5.
Silverberg Bernstein Capital Management LLC(2.3711%)
since
2025/06/30
6.
Commonwealth Equity Services Inc(1.7545%)
since
2025/06/30
7.
Horizon Asset Management Inc/ny(1.6261%)
since
2025/06/30
8.
BlackRock Inc(1.3299%)
since
2025/06/30
9.
Taylor Frigon Capital Management LLC(1.2663%)
since
2025/06/30
10.
Geode Capital Management, LLC(0.9245%)
since
2025/06/30
11.
Private Advisor Group, LLC(0.7664%)
since
2025/06/30
12.
Perkins Capital Management Inc(0.6002%)
since
2025/06/30
13.
Kingsview Wealth Management, LLC(0.5066%)
since
2025/06/30
14.
Renaissance Technologies Corp(0.4796%)
since
2025/06/30
15.
Perceptive Advisors LLC(0.3966%)
since
2025/06/30
16.
Northern Trust Corp(0.315%)
since
2025/06/30
17.
State Street Corp(0.289%)
since
2025/06/30
18.
Caption Management, LLC(0.2848%)
since
2025/06/30
19.
Dimensional Fund Advisors, Inc.(0.1991%)
since
2025/06/30
20.
Bridgeway Capital Management, LLC(0.1629%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.